Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study. Thromb Haemost. 2014 Sep 02; 112(3):445-58.
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
Antibodies, Blocking
Antibodies, Blocking
Antibodies, Monoclonal, Murine-Derived
Antibodies, Monoclonal, Murine-Derived
Antibody Formation
Antibody Formation
Antigens, CD20
Antigens, CD20
Blood Coagulation
Blood Coagulation
Child
Child
Child, Preschool
Child, Preschool
Factor VIII
Factor VIII
Follow-Up Studies
Follow-Up Studies
Hemophilia A
Hemophilia A
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Male
Male
Rituximab
Rituximab
Treatment Outcome
Treatment Outcome
United States
United States
Young Adult
Young Adult